{"id":307807,"date":"2019-11-29T20:00:05","date_gmt":"2019-11-30T04:00:05","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/11\/healthcare-roundup-tetra-bio-pharma-receives-orphan-drug-designation-fibrogen-6-3\/"},"modified":"2019-11-29T23:19:06","modified_gmt":"2019-11-30T07:19:06","slug":"%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8tetra-bio-pharma-%e5%ad%a4%e5%85%92%e8%97%a5%e8%b3%87%e8%b3%aa-fibrogen-%e4%b8%8a%e6%bc%b2","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/11\/%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8tetra-bio-pharma-%e5%ad%a4%e5%85%92%e8%97%a5%e8%b3%87%e8%b3%aa-fibrogen-%e4%b8%8a%e6%bc%b2\/","title":{"rendered":"\u91ab\u7642\u4fdd\u5065\u7cbe\u9078\u2014\u2014Tetra Bio-Pharma\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u8cea\uff0cFibroGen\u4e0a\u6f326.3%"},"content":{"rendered":"

Tetra Bio-Pharma\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c<\/h2>\n

Tetra Bio-Pharma\uff08TBPMF-1.9%\uff09<\/a>\u6cbb\u7642\u809d\u764c\u7684\u85e5\u7269\uff08Delta-9-Tetrahydrocannabinol\uff09\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u8cea\u3002<\/p>\n

Tetra Bio-Pharma\u80a1\u50f9\u4e0a\u6f3210.5%\u3002<\/p>\n

\u5b89\u9032\u7372\u5f97\u8ca7\u8840\u6cbb\u7642\u7684\u5b64\u5152\u85e5\u8cc7\u683c<\/h2>\n

\u5b89\u9032\u516c\u53f8\uff08NASDAQ\uff1aAMGN\uff09<\/a>\u7528\u4f5c\u6cbb\u7642\u518d\u751f\u969c\u7919\u6027\u8ca7\u8840\u7684Nplate\uff08romiplostim\uff09\u7372\u5f97\u4e86\u5b64\u5152\u85e5\u8cc7\u8cea\u3002\u5982\u679c\u6279\u51c6\u8a72\u6cbb\u7642\u65b9\u6848\uff0c\u90a3\u5c07\u610f\u5473\u8457\u4e03\u5e74\u7684\u5e02\u5834\u5c08\u6709\u6b0a\u3002<\/p>\n

\u8a72\u516c\u53f8\u80a1\u50f9\u6301\u7e8c\u4e0a\u6f32\uff0c\u904e\u53bb\u4e00\u500b\u6708\u4e0a\u6f32\u4e8612.2%\uff0c\u904e\u53bb\u516d\u500b\u6708\u4e0a\u6f32\u4e8640.7%\u3002<\/p>\n

FibroGen\u4e0a\u6f326.3%<\/h2>\n

SVB Leerink\u5c0d\u8a72roxadustat\u9032\u884c\u4e86\u7a4d\u6975\u8a55\u50f9\uff0c\u8a8d\u70ba\u4f86\u81ea\u300a\u4e2d\u570b\u91ab\u4fdd\u85e5\u54c1\u76ee\u9304\u300b\u7684\u5efa\u8b70\u5c07\u63a8\u52d5\u92b7\u91cf\u589e\u9577\uff0c\u7531\u6b64FibroGen\uff08NASDAQ\uff1aFGEN\uff09<\/a>\u7684\u80a1\u50f9\u4e0a\u6f326.3%\u3002<\/p>\n

\u4ed6\u8aaa\uff0cFibroGen\u7684roxadustat\u5728\u300a\u4e2d\u570b\u91ab\u4fdd\u85e5\u54c1\u76ee\u9304\u300b\u4e2d\u7684\u6307\u5c0e\u50f9\u5f88\u53ef\u80fd\u70ba95.5\u5143\/\u7247\uff0c\u6298\u5408\u6bcf\u6708177\u7f8e\u5143\/\u5e74\u548c2128\u7f8e\u5143\/\u5e74\uff0c\u9ad8\u65bc\u5206\u6790\u5e2bGeoffrey Porges\u7684\u9810\u671f1600\u7f8e\u5143\/\u5e74\u3002<\/p>\n

\u4ed6\u5beb\u9053\uff0c\u66f4\u9ad8\u7684\u552e\u50f9\u53ef\u80fd\u610f\u5473\u8457\u8a72\u516c\u53f8\u7684\u80a1\u50f9\u5c07\u4e0a\u6f325\u7f8e\u5143\u3002<\/p>\n

Leerink\u7d66\u4e88\u8dd1\u8d0f\u5927\u76e4\u80a1\u7968\u8a55\u7d1a\uff0c\u76ee\u6a19\u50f9\u683c\u70ba84\u7f8e\u5143\uff0c\u70ba\u5e02\u5834\u6700\u9ad8\u50f9\uff0c\u8f03\u76ee\u524d\u670995%\u7684\u4e0a\u6f32\u7a7a\u9593\u3002<\/p>\n

Myovant\u80a1\u50f9\u4e0a\u6f323.6%<\/h2>\n

\u81ea\u5f9e\u516c\u958b\u62ab\u9732Roivant Sciences\u540c\u610f\u5f9eMillennium Pharma\u8cfc\u8cb7350\u842c\u80a1Myovant\u80a1\u4efd\u7684\u6587\u4ef6\u4ee5\u4f86\uff0cMyovant Sciences\uff08NYSE\uff1aMYOV\uff09<\/a>\u4e0a\u6f32\u4e863.6%\u3002Roivant\u5728Myovant\u7684\u80a1\u4efd\u589e\u81f349.7%\u3002<\/p>\n

\u8463\u4e8b\u9577\u8cfc\u8cb7\u80a1\u7968\u5f8c\uff0cXeris\u4e0a\u6f325%<\/h2>\n

Xeris Pharmaceuticals\uff08NASDAQ\uff1aXERS\uff09<\/a>\u80a1\u50f9\u5728\u5047\u65e5\u5f8c\u7684\u4ea4\u6613\u4e2d\u4e0a\u6f32\u4e865%\uff0c\u6b64\u524d\u8a72\u516c\u53f8\u62ab\u9732\u8463\u4e8b\u9577\u517c\u9996\u5e2d\u57f7\u884c\u5b98Paul Edick\u672c\u5468\u8cfc\u8cb7\u4e8617,935\u80a1\u3002<\/p>\n

\u8a72\u516c\u53f8\u80a1\u7968\u6700\u8fd1\u5e7e\u5468\u4e00\u76f4\u6ce2\u52d5\uff0c\u4f46\u5728\u904e\u53bb\u4e00\u500b\u5b63\u5ea6\u4e0b\u8dcc\u4e8625.9%\uff0c\u4e26\u4e14\u5e74\u521d\u81f3\u4eca\u4e0b\u8dcc\u4e86\u8fd150%\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

Tetra Bio-Pharma (TBPMF -1.9%) has received orphan drug designation for its treatment (Delta-9-Tetrahydrocannabinol) for hepatocellular carcinoma. Shares are up 10.5% in Toronto.<\/p>\n","protected":false},"author":9,"featured_media":307796,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,564],"class_list":["post-307807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/307807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=307807"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/307807\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/307796"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=307807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=307807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=307807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}